PGXL was founded with the mission of enabling and advancing the practice of personalized medicine. It has been delivering pharmacogenetic test results and interpretations since 2001, and is certified by CLIA and CAP.
The company operates as both a commercial and research laboratory. By straddling these two very different worlds, it is engaged with the development of personalized medicine at the level of discovery, assay development and clinical testing. Physicians and researchers using PGXL’s services can be sure they’re getting the very best science available.
The broad application of pharmacogenetics to personalized medicine will, we believe, improve patient outcomes and lower healthcare costs. We see no greater cause than helping physicians bring personalized medicine to standard medical practice.